GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Sale Of Property, Plant, Equipment

Kane Biotech (TSXV:KNE) Sale Of Property, Plant, Equipment : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech Sale Of Property, Plant, Equipment?

Kane Biotech's sale of property, plant, equipment for the three months ended in Sep. 2024 was C$0.00 Mil. It means Kane Biotech gained C$0.00 Mil from selling property, plant, and equipment. Kane Biotech's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Jun. 2024 ), Kane Biotech gained the same money from selling property, plant, and equipment in Sep. 2024 (C$0.00 Mil).

Kane Biotech Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Kane Biotech's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Sale Of Property, Plant, Equipment Chart

Kane Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kane Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kane Biotech Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
XCNQ:PREV TSX:CSCI XCNQ:BIOV TSXV:HEM TSX:RVX TSX:APS XCNQ:BLAB XCNQ:BETR TSXV:SBM XCNQ:MDMA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
KNBIF:USA
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Website
https://www.kanebiotech.com
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.
Executives
Marc Edwards Director
Philip Renaud Director
Raymond David Eugene Dupuis Senior Officer
Richard J. Renaud 10% Security Holder
Georges Morin Director
Rashieda Gluck Director

Kane Biotech Headlines

No Headlines